Navigation Links
First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA

(HR=0.58, 95% CI [0.40-0.83], p=0.0024) compared to the AC-T control arm. There was no statistically significant difference in OS between the two experimental arms (TCH and AC-TH).

Moreover, with the TCH regimen, the risk of congestive heart failure was five-fold lower compared to that observed with AC-TH (0.4% vs 1.9% vs 0.3% in women treated with TCH, AC-TH, and AC-T respectively).

"The BCIRG 006 trial results give us a new option for the treatment of HER2 positive breast cancer. This approach exploits the most recent molecular information regarding the HER2 alteration allowing us to retain the remarkable benefits of Herceptin while leaving behind almost all of the major side effects," said Professor Dennis Slamon, Professor and Chief Hematology-Oncology UCLA Los Angeles and CIRG Chair. "The BCIRG design, while initially received controversially, was based on clean preclinical evidence that led us to test a novel combination of drugs in breast cancer."

About BCIRG 006

The BCIRG 006 was a phase III multicenter study conducted by the CIRG and sponsored by sanofi-aventis (Paris, France) with additional support from Genentech (South San Francisco, USA).

Study design

3,222 women with HER2-positive node-positive and high-risk node-negative operable breast cancer were enrolled and randomly assigned to one of the following treatments:

- AC-T (n=1,073), the anthracycline-containing control regimen consisting

of doxorubicin (A, 60 mg/m2) plus cyclophosphamide (C, 600 mg/m2) every

three weeks for four cycles followed by Taxotere(R) (T, 100 mg/m2)

every three weeks for four cycles.

- AC-TH (n=1.074), the anthracycline-containing experimental regimen

consisting of AC every three weeks for four cycles followed by

Taxotere(R) (T, 100 mg/m2) every three weeks for four cycles plus

Herceptin(R) (H, 4 mg/kg loading dose followed by 2 mg/kg per week

concurrently with

SOURCE Cancer International Research Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
(Date:7/21/2014)... tension to a chain of carbon atoms can turn ... to Rice University scientists. , Stretching the material known ... atoms -- by just 3 percent can begin to ... useful for mechanically activated nanoscale electronics and optics. , ... his colleagues appears in the American Chemical Society journal ...
(Date:7/21/2014)... July 21, 2014  Mike Patterson, CEO of ... million in Series Seed B funding to finance ... for the life science, defense, intelligence, and environmental ... led the round and was joined by R2M ... Said Patterson , "This round of funding will ...
(Date:7/20/2014)... Wash. -- When nuclear fuel gets recycled, the process ... in rock contaminates basements with the related gas radon. ... gases, and research appearing July 20 in Nature ... the gases in but not out. , The ... hazardous radioactive elements from nuclear fuel or air in ...
(Date:7/18/2014)... , July 18, 2014 Regeneron Pharmaceuticals, Inc. ... quarter 2014 financial and operating results on Tuesday, August ... Company will host a conference call and simultaneous webcast ... Conference Call InformationTo access this call, dial (888) ... the webcast may be accessed from the ,Events and ...
Breaking Biology Technology:Carbyne morphs when stretched 2Carbyne morphs when stretched 3Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology 2A noble gas cage 2A noble gas cage 3
... - Merge Technologies, Inc. , a developer ... and services, announced its second quarter results Tuesday morning, ... was at a record high of $18.8 million, the ... or $0.62 per share, owing largely to merger and ...
... It's not surprising that Gov. Jim Doyle and the ... state's latest budget will treat public school districts across ... without hurting taxpayers; the Republicans believe Doyle abused his ... card. , ,The debate over how to pay for ...
... (iBIO) recently held its annual event entitled Breakfast With the ... & Technology Park in Skokie, Ill. It was an auspicious ... VCs present were Midwest VCs that were actually funding deals. ... park, which many people hasnt yet visited. , The mayor ...
Cached Biology Technology:Cedara acquisition costs hit Merge Technologies numbers 2Before deciding how to pay for K-12 schools, let's determine what to buy 2Before deciding how to pay for K-12 schools, let's determine what to buy 3Midwest venture capital funding declines in first half of 2005 2Midwest venture capital funding declines in first half of 2005 3
(Date:7/21/2014)... and cheating in science are among the topics ... mycology experts in Montreal at the three International ... 27 to August 1, 2014. Some 2,000 participants ... the 14th International Congress of Bacteriology and Applied ... Eukaryotic Microbiology, and the 16th International Congress of ...
(Date:7/21/2014)... Researchers have streamlined and simplified a process that uses ... water, reducing levels of harmful bacteria by 90% to ... cultivated widely throughout many countries of Africa, Asia, and ... a Current Protocols in Microbiology review, is ... living in extreme poverty in developing countries who are ...
(Date:7/21/2014)... Mass. New studies being launched by neurobiologist ... will investigate how estrogens produced in the brains ... songs during a critical window during development. This ... in human children. , In a separate study, ... the idea that estrogens produced in the brain,s ...
Breaking Biology News(10 mins):Montreal hosts International Union of Microbiology Societies congresses 2Studying estrogens made by the brain may offer new insights in learning and memory 2Studying estrogens made by the brain may offer new insights in learning and memory 3
... May 7 Scientists from across the ... to advocate for increased funding for federal science agencies as part ... (FASEB) annual Capitol Hill Day.  Led by FASEB President, Dr. ... and attended breakfast events with two members of the Senate Appropriations ...
... Professor Jos Zanchetta, a member of the IOF ... American Programme, has been named the recipient of the ... the International Osteoporosis Foundation (IOF) in memory of Pierre ... in the growth of the Foundation and osteoporosis advocacy ...
... is available in Spanish . , Algae--already ... right away to remove nitrogen and phosphorus in livestock ... scientist. That could give resource managers a new eco-friendly ... contaminate water quality in the Chesapeake Bay. ...
Cached Biology News:FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding 2Algae advances as a 'green' alternative for improving water quality 2
Request Info...
Request Info...
Image Analysis Software. PC Version of NIH Image....
... siRNA service provides the premium quality siRNAs ... Custom siRNAs can be readily ordered online ... sequence, or by providing the sense and ... Silencer Validated and Silencer Pre-designed siRNAs, which ...
Biology Products: